Associate Professor
Karmanos Cancer Institute-Wayne State and Michigan State University
Detroit, Michigan, United States
Craig Emmitt Cole, M.D. is a board-certified Hematologist who received his Bachelor of Science degree in physiology at Michigan State University/College of Lyman Briggs, in East Lansing Michigan. Dr. Cole went to receive his doctoral degree at Ohio State University College of Medicine in Columbus, Ohio. He completed his Internal Medicine Residency and Hematology/Oncology Fellowship at the University of Michigan, Ann Arbor. He subsequently had a post-fellowship laboratory research position at the Jerome Lipper Multiple Myeloma Center of Medicine at Dana-Farber Cancer Institute in Boston, Massachusetts. This opportunity led to him become an attending hematologist at Gundersen Health System in La Crosse, Wisconsin. There he was an instructor for both the medical and nursing schools of the western campus of the University of Wisconsin School of Medicine. He also served as Affiliate Faculty Member of Graduate Community Health Programs and Assistant Professor at the University of Wisconsin-La Crosse, Department of Health Professions. He then returned to the University of Michigan in Ann Arbor, Michigan as an Assistant Professor with his primary clinical and research interest in multiple myeloma. He then returned to Michigan State University College of Human Medicine and in the summer of 2024 joined the myeloma program at Karmanos Cancer Insititue - Wayne State University School of Medicine in Detroit, Michigan. He is a member of the International Myeloma Working Group, International Myeloma Society and the American Society of Hematology. Dr. Cole has published in national journals and presented his research at the International Myeloma Society, American Society of Hematology and the American Society for Apheresis meetings. He has won awards for his work in teaching, myeloma research, and patient advocacy. Dr. Cole has always had a strong commitment to equity of cancer care and community education by working with several local and national patient advocacy.
Disclosure information not submitted.
Saturday, September 28, 2024
8:25 AM – 8:33 AM East Coast USA Time
Discuss the use of BCMA-directed BsAb therapies in clinical practice
Saturday, September 28, 2024
8:45 AM – 8:55 AM East Coast USA Time